Log in to save to my catalogue

After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed A...

After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed A...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c7f4f183bd5b4a728e87bee63be4029a

After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia

About this item

Full title

After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

Journal title

Journal of immunology research, 2020-11, Vol.2020 (2020), p.1-11

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

More information

Scope and Contents

Contents

An emerging body of evidence demonstrates that defects in antileukemic effector cells in patients with acute myeloid leukemia (AML) can contribute to the development and/or persistence of the disease. In particular, immune suppressive regulatory T cells (Tregs) may contribute to this defective antileukemic immune response, being recruited by bone m...

Alternative Titles

Full title

After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c7f4f183bd5b4a728e87bee63be4029a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c7f4f183bd5b4a728e87bee63be4029a

Other Identifiers

ISSN

2314-8861

E-ISSN

2314-7156

DOI

10.1155/2020/2134647

How to access this item